This data underscores the durability, safety, and efficacy of Optilume as a minimally invasive option for patients. The study evaluated 53 men with recurrent bulbar strictures, concluding that 71. ...
The groundbreaking treatment for recurrent bulbar urethral strictures has had its five-year follow-up data from the ROBUST I study published in the Journal of Urology. This data underscores the ...
Optilume provides durable, long-term relief for urethral strictures, with significant improvements in IPSS, Qmax, and PVR over 5 years. The 5-year freedom from repeat intervention rate was 71.7%, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results